Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Mandler

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Vaccines|September 23, 2022
A Novel C-Type Lectin Receptor-Targeted α-Synuclein-Based Parkinson Vaccine Induces Potent Immune Responses and Therapeutic Efficacy in MiceSabine Schmidhuber, Sandra Scheiblhofer, Richard Weiss, et al.
Molecular Imaging and Biology|February 14, 2009
Limitations of small animal PET imaging with [18F]FDDNP and FDG for quantitative studies in a transgenic mouse model of Alzheimer's diseaseClaudia Kuntner, Adam L Kesner, Martin Bauer, et al.
Acta Neuropathologica|February 15, 2014
Next-generation active immunization approach for synucleinopathies: implications for Parkinson's disease clinical trialsMarkus Mandler, Elvira Valera, Edward Rockenstein, et al.
Molecular Neurodegeneration|April 18, 2015
Active immunization against alpha-synuclein ameliorates the degenerative pathology and prevents demyelination in a model of multiple system atrophyMarkus Mandler, Elvira Valera, Edward Rockenstein, et al.
Acta Neuropathologica|May 28, 2014
Pyroglutamylated amyloid-β is associated with hyperphosphorylated tau and severity of Alzheimer's diseaseMarkus Mandler, Lauren Walker, Radmila Santic, et al.
Scientific Reports|August 30, 2018
Evaluation of modified Interferon alpha mRNA constructs for the treatment of non-melanoma skin cancerSarah Hochmann, Michaela Mittermeir, Radmila Santic, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|August 6, 2019
Effects of single and combined immunotherapy approach targeting amyloid β protein and α-synuclein in a dementia with Lewy bodies-like modelMarkus Mandler, Edward Rockenstein, Cassia Overk, et al.
Molecular Therapy. Nucleic Acids|August 31, 2023
Improved tropoelastin synthesis in the skin by codon optimization and nucleotide modification of tropoelastin-encoding synthetic mRNASonia Golombek, Thomas Hoffmann, Ludmilla Hann, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Vaccines|September 23, 2022
A Novel C-Type Lectin Receptor-Targeted α-Synuclein-Based Parkinson Vaccine Induces Potent Immune Responses and Therapeutic Efficacy in MiceSabine Schmidhuber, Sandra Scheiblhofer, Richard Weiss, et al.
Molecular Imaging and Biology|February 14, 2009
Limitations of small animal PET imaging with [18F]FDDNP and FDG for quantitative studies in a transgenic mouse model of Alzheimer's diseaseClaudia Kuntner, Adam L Kesner, Martin Bauer, et al.
Acta Neuropathologica|February 15, 2014
Next-generation active immunization approach for synucleinopathies: implications for Parkinson's disease clinical trialsMarkus Mandler, Elvira Valera, Edward Rockenstein, et al.
Molecular Neurodegeneration|April 18, 2015
Active immunization against alpha-synuclein ameliorates the degenerative pathology and prevents demyelination in a model of multiple system atrophyMarkus Mandler, Elvira Valera, Edward Rockenstein, et al.
Acta Neuropathologica|May 28, 2014
Pyroglutamylated amyloid-β is associated with hyperphosphorylated tau and severity of Alzheimer's diseaseMarkus Mandler, Lauren Walker, Radmila Santic, et al.
Scientific Reports|August 30, 2018
Evaluation of modified Interferon alpha mRNA constructs for the treatment of non-melanoma skin cancerSarah Hochmann, Michaela Mittermeir, Radmila Santic, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|August 6, 2019
Effects of single and combined immunotherapy approach targeting amyloid β protein and α-synuclein in a dementia with Lewy bodies-like modelMarkus Mandler, Edward Rockenstein, Cassia Overk, et al.
Molecular Therapy. Nucleic Acids|August 31, 2023
Improved tropoelastin synthesis in the skin by codon optimization and nucleotide modification of tropoelastin-encoding synthetic mRNASonia Golombek, Thomas Hoffmann, Ludmilla Hann, et al.
Pageof 2